Other substances

L3 Azo imidazole

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

L3 Azo imidazole derivative is an experimental drug synthetized and characterized by Chhetri et al. (2020).

 

Supporting references

Link Tested on Impact factor Notes Publication date
Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (Mpro): A computational study
3CLpro Small molecule In silico 		in silico 2.46

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Oct/02/2020
Export (.csv)